Cyclerion Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Cyclerion Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $2.30 million for the year ending 2020.

  • Cyclerion Therapeutics, Inc. showed a decrease of -49.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2019 to 2020.
  • This data is from Cyclerion Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2021.
  • XBRL data for this metric is available from 2019 to 2020 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2020: $2.30 million | Fiscal year 2019: $4.51 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: